On the HCPLive gout page, resources on the topics of medical news and expert insight into gouty arthritis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on gout, and more.
October 19th 2024
The treatment did seem to blunt the glycemic response and influence some inflammatory cytokines.
Phase 3 DISSOLVE Trials Prove SEL-212's Urate-Lowering Ability in Chronic Gout
March 21st 2023An announcement from Selecta Biosciences and Sobi provide the latest update on DISSOLVE clinical program, with new data indicating SEL-212 met the primary endpoint of achieving serum urate control during month 6.
Temporary Increase in Venous Thromboembolism Observed After Gout Flare
A brief increase in venous thromboembolism (VTE) was reported within 30 days after a hospitalization or primary care visit for gout flare. The highest incidence occurred during the 16-30 day period after the flare.
Quality of Life Less Impacted by Gout than Other Inflammatory Joint Diseases
February 9th 2023An analysis of survey data from more than 2000 patients in Western Sweden is providing insight into how the impact of inflammatory joint disease on health-related quality of life differs among those with gout, RA, PsA, and ankylosing spondylitis.
Significant Decreases in Tophus, Double Contour Sign Observed in Patients With Gout Receiving ULT
Musculoskeletal ultrasound evaluated tophus size and double contour sign in lower extremity joints of patients with gout before and after initiating uric acid lowering therapy.
DECT Scoring System Proves to be a Noninvasive, Effective Tool for Gout Diagnosis
The DECT scoring system obtained excellent diagnostic performance for differentiating early-stage gout from middle-stage gout, with sensitivity, positive and negative predictive values, and specificity all achieving an accuracy of > 85%.
Increased Risk of Hospitalization, Death Observed in Patients with Gout and COVID-19
Understanding the risk factors, such as a gout diagnosis and long-term glucocorticoid use, can help inform patients and clinicians regarding the continued management of patients with rheumatic disease during the COVID-19 pandemic.
Pegloticase and Methotrexate Co-Therapy Improved Urate Burden, Patient-Reported Outcomes in Gout
Serum urate rapidly declined after initiation of pegloticase and methotrexate therapy and was maintained well below ≥ 6 mg/dL, an indicator of uncontrolled gout, throughout the study.
Clinical Updates in Gout Management, with Tarun Sharma, MD
November 30th 2022Tarun Sharma, MD, a rheumatologist with the Allegheny Health Network who helped author the American College of Rheumatology's most recent gout guidelines, sits down to provide perspective on the latest updates in gout from 2022, including new trial data, regulatory news and updates, and a glimpse into what he is most excited for in 2023.